4,055
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway

, MD, PhDORCID Icon & , ND

References

  • Anciones C, Gil-Nagel A. 2020. Adverse effects of cannabinoids. Epileptic Disord. 22(S1):29–32. doi:10.1684/epd.2019.1125. PMID: 31941644.
  • Cogan PS. 2020a. Reality and legality: disentangling what is actual from what is tolerated in comparisons of hemp extracts with pure CBD. J Diet Suppl.
  • Cogan PS. 2020b. Practical considerations of hypotheses and evidence in cannabis pharmacotherapy: refining expectations of clinical endocannabinoid deficiency. J Diet Suppl.:1–17. doi:10.1080/19390211.2020.1769246.Epub ahead of print. PMID: 32449630.
  • Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, et al. 2018. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome. N Engl J Med. 378(20):1888–1897. PMID: 29768152. doi:10.1056/NEJMoa1714631.
  • Ewing LE, McGill MR, Yee EU, Quick CM, Skinner CM, Kennon-McGill S, Clemens M, Vazquez JH, McCullough SS, Williams DK, et al. 2019b. Paradoxical patterns of sinusoidal obstruction syndrome-like liver injury in aged female CD-1 mice triggered by cannabidiol-rich cannabis extract and acetaminophen co-administration. Molecules. 24(12):2256. doi:10.3390/molecules24122256.
  • Ewing LE, Skinner CM, Quick CM, Kennon-McGill S, McGill MR, Walker LA, ElSohly MA, Gurley BJ, Koturbash I. 2019a. Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model. Molecules. 24(9):1694. PubMed PMID: 31052254; PubMed Central PMCID: PMC6539990. doi:10.3390/molecules24091694.
  • Gurley BJ, Miousse IR, Nookaew I, Ewing LE, Skinner CM, Jenjaroenpun P, Wongsurawat T, Kennon-McGill S, Avula B, Bae JY, et al. 2019. Decaffeinated green tea extract does not elicit hepatotoxic effects and modulates the gut microbiome in lean B6C3F1 mice. Nutrients. 11(4):776. Apr 3pii: PubMed PMID: 30987244; PubMed Central PMCID: PMC6521095. doi:10.3390/nu11040776.
  • Gurley BJ, Murphy TP, Gul W, Walker LA, ElSohly M. 2020. Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi. J Diet Suppl.:1–9. doi:10.1080/19390211.2020.1766634.Epub ahead of print. PMID: 32431186.
  • Henning SM, Yang J, Hsu M, Lee RP, Grojean EM, Ly A, Tseng CH, Heber D, Li Z. 2018. Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice. Eur J Nutr. 57(8):2759–2769. doi:10.1007/s00394-017-1542-8.Epub 2017 Sep 30.
  • Karimian Azari E, Kerrigan A, O’Connor A. 2020. Naturally occurring cannabinoids and their role in modulation of cardiovascular health. J Diet Suppl.
  • Lopez HL, Cesareo KR, Raub B, Kedia AW, Sandrock JE, Kerksick CM, Ziegenfuss TN. 2020. Effects of hemp extract on markers of wellness, stress resilience, recovery and clinical biomarkers of safety in overweight, but otherwise healthy subjects. J Diet Suppl.:1–26. doi:10.1080/19390211.2020.1765941.Epub ahead of print. PMID: 32456572.
  • Marinotti O, Sarill M. 2020. Differentiating full-spectrum hemp extracts from CBD isolates: implications for policy, safety and science. J Diet Suppl. 16:1–10. doi:10.1080/19390211.2020.1776806.Epub ahead of print. PMID: 32543253.
  • Schmitz SM, Lopez HL, Marinotti O. 2020. Post marketing safety of plus CBD™ products, a full spectrum hemp extract: a 2-year experience. J Diet Suppl.:1–12. doi:10.1080/19390211.2020.1767255.Epub ahead of print. PMID: 32449632.
  • Skinner CM, Nookaew I, Ewing LE, Wongsurawat T, Jenjaroenpun P, Quick CM, Yee EU, Piccolo BD, ElSohly M, Walker LA, et al. 2020. Potential probiotic or trigger of gut inflammation - the janus-faced nature of cannabidiol-rich cannabis extract. J Diet Suppl. 13:1–18. doi:10.1080/19390211.2020.1761506.Epub ahead of print. PMID: 32400224.
  • Tallon M. 2020. Cannabis Sativa L. and its extracts: the regulation of cannabidiol in the European Union and United Kingdom. J Diet Suppl.
  • Walker LA, Koturbash I, Kingston R, ElSohly MA, Yates CR, Gurley BJ, Khan I. 2020. Cannabidiol (CBD) in dietary supplements: perspectives on science, safety, and potential regulatory approaches. J Diet Suppl. 16:1–10. doi:10.1080/19390211.2020.1777244.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.